HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics

U.S. Department of Health and Human Services

Co-chairs
Deborah Dowell, MD, MPH (CDC) Christopher Jones, PharmD, DrPH (CDC) Wilson Compton, MD, MPE (NIH)

Workgroup members
Elisabeth Kato, MD, MRP (AHRQ) Joel Dubenitz, PhD (ASPE) Shari Ling, MD (CMS) Daniel Foster, DO, MS, MPH (FDA) Sharon Hertz, MD (FDA) Marta Sokolowska, PhD (FDA) Judith Steinberg, MD, MPH (HRSA) Meena Vythilingam, MD (OASH) Thomas Clarke, PhD (SAMHSA)

September 2019. U.S. Department of Health and Human Services

To view, copy or download the HHS’s 8 page version of the guide go to the link listed below.

https://lookaside.fbsbx.com/file/8-Page%20version__HHS%20Guidance%20for%20Dosage%20Reduction%20or%20Discontinuation%20of%20Opioids.pdf?token=AWxgnl0bqMBN0e_8SrqpW8MPYqvnQCrRC0nw9qjbePmZaCDjKZMiF-FkwJvTzAnFJmuiymTH8d70jQJ13NZaKCOxR5_-_UnTf9VFxI_ZtAU9kqJ-uJT3JJbsysKcGJ41TSWe-sx2yGkT-tKRGy5uu6XlEgagG_MzemwYIgrI6n32WYpXKZMz9gkgw8FsKgzDK9tajL39GdEr4lELyiyFLzyt

Tags: HHS, U.S Department of Health and Human Services, guidance, reduction, discontinuation,